GlassScriptPhysician profile
Paul Reichman
NPI 1225114978
$1,358.99
in general payments reported to CMS, 2019-2025
14 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2021: $230 · 2022: $209 · 2023: $412 · 2024: $198 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $744.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $269.57 | 2021-2024 | Aponvie, Zynrelef |
| Inari Medical, INC. | $186.48 | 2022 | |
| Kci USA, INC. | $178.87 | 2023 | Prevena, V.A.C. Veraflo, Activ.A.C. Ion Progress |
| Bard Access Systems, INC. | $176.28 | 2019 | |
| Davol INC. | $143.81 | 2022-2024 | Phasix Mesh |
| Abbvie INC. | $105.87 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $85.00 | 2021 | |
| Hologic Sales and Service, LLC | $71.30 | 2023 | Localizer |
| Organogenesis INC. | $28.52 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $27.47 | 2025 | |
| Kerecis Limited | $24.61 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Teleflex LLC | $23.28 | 2023 | Urolift |
| Integra Lifesciences Corporation | $21.98 | 2023 | Integra, Surgimend, Omnigraft |
| Medtronic, INC. | $15.95 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Reichman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.